<https://medicaltrend.org/2021/05/18/new-drug-for-metastatic-breast-cancer-mbc-halaven-eribulin/#webpage>
<http://schema.org/description>
"New drug for metastatic breast cancer (mBC): Halaven (Eribulin). Eribulin is the first halichondrin-based microtubule kinetics inhibitor with a new mechanism of action. Eribulin is thought to work mainly through a tubulin-based mechanism that causes long-term irreversible mitotic arrest and ultimately leads to the death of apoptotic cells."
<https://medicaltrend.org/2021/05/18/new-drug-for-metastatic-breast-cancer-mbc-halaven-eribulin/>